Semanteon Capital Management LP Takes $1.21 Million Position in Aspen Aerogels, Inc. (NYSE:ASPN)

Semanteon Capital Management LP acquired a new stake in Aspen Aerogels, Inc. (NYSE:ASPNFree Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 76,761 shares of the construction company’s stock, valued at approximately $1,211,000. Aspen Aerogels accounts for 0.8% of Semanteon Capital Management LP’s investment portfolio, making the stock its 25th biggest holding.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Vanguard Group Inc. increased its position in Aspen Aerogels by 0.4% in the 3rd quarter. Vanguard Group Inc. now owns 3,445,887 shares of the construction company’s stock valued at $29,635,000 after buying an additional 14,013 shares in the last quarter. AIGH Capital Management LLC bought a new stake in Aspen Aerogels in the 3rd quarter valued at about $15,067,000. Federated Hermes Inc. increased its position in Aspen Aerogels by 53.9% in the 4th quarter. Federated Hermes Inc. now owns 1,154,042 shares of the construction company’s stock valued at $18,211,000 after buying an additional 404,042 shares in the last quarter. UniSuper Management Pty Ltd increased its position in Aspen Aerogels by 13.5% in the 3rd quarter. UniSuper Management Pty Ltd now owns 1,083,836 shares of the construction company’s stock valued at $9,321,000 after buying an additional 128,974 shares in the last quarter. Finally, Rice Hall James & Associates LLC increased its position in Aspen Aerogels by 385.0% in the 3rd quarter. Rice Hall James & Associates LLC now owns 623,135 shares of the construction company’s stock valued at $5,359,000 after buying an additional 494,662 shares in the last quarter. 97.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of brokerages recently commented on ASPN. Canaccord Genuity Group boosted their target price on Aspen Aerogels from $13.00 to $17.00 and gave the company a “buy” rating in a research report on Wednesday, December 27th. Canaccord Genuity Group boosted their price objective on Aspen Aerogels from $13.00 to $17.00 and gave the stock a “buy” rating in a report on Wednesday, December 27th. Roth Mkm started coverage on Aspen Aerogels in a report on Wednesday, March 6th. They set a “buy” rating and a $22.00 price objective for the company. TheStreet raised Aspen Aerogels from a “d+” rating to a “c-” rating in a report on Wednesday, March 6th. Finally, HC Wainwright reissued a “buy” rating and set a $20.00 price objective on shares of Aspen Aerogels in a report on Wednesday, February 14th. One analyst has rated the stock with a sell rating and five have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Aspen Aerogels has an average rating of “Moderate Buy” and an average target price of $19.00.

Check Out Our Latest Stock Report on ASPN

Aspen Aerogels Stock Performance

Shares of ASPN stock traded down $0.94 during trading on Thursday, hitting $15.70. The company’s stock had a trading volume of 630,732 shares, compared to its average volume of 959,763. The company has a market cap of $1.21 billion, a PE ratio of -23.79 and a beta of 2.04. The company has a current ratio of 3.41, a quick ratio of 2.91 and a debt-to-equity ratio of 0.24. The business has a fifty day moving average of $16.52 and a 200-day moving average of $13.25. Aspen Aerogels, Inc. has a 52 week low of $5.32 and a 52 week high of $19.10.

Aspen Aerogels (NYSE:ASPNGet Free Report) last released its earnings results on Tuesday, February 13th. The construction company reported ($0.01) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.12) by $0.11. The company had revenue of $84.22 million during the quarter, compared to analyst estimates of $83.82 million. Aspen Aerogels had a negative return on equity of 10.47% and a negative net margin of 19.19%. During the same period in the prior year, the company posted ($0.20) earnings per share. As a group, research analysts anticipate that Aspen Aerogels, Inc. will post -0.24 earnings per share for the current year.

About Aspen Aerogels

(Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Recommended Stories

Want to see what other hedge funds are holding ASPN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aspen Aerogels, Inc. (NYSE:ASPNFree Report).

Institutional Ownership by Quarter for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.